Insider Trading & Ownership of Laura Clague

Location: Escondido, CA
Summary: The estimated net worth of Laura Clague is at least $1,247,634 dollars as of 16 Jun 2023. Laura Clague is the Director of Genasys Inc. and owns shares of Genasys Inc. (GNSS) stock worth about $529.7K. Laura Clague is the Director of STANDARD BIOTOOLS INC. and owns shares of STANDARD BIOTOOLS INC. (LAB) stock worth about $398.5K. Laura Clague is the Chief Financial Officer of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $319.5K.
Signature: /s/ Laura Clague by Agnieszka Gallagher, Attorney-in-Fact
All Insider Reports: All Insider Reports

Follow Filing Activity

Follow Laura Clague and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

Laura Clague has 3 issuer positions tracked on this page.
Estimated disclosed ownership value: $1,247,634.
Recent insider filing activity is available below.

What Changed

Largest disclosed position: Genasys Inc. ($529,675).
Past-year value change for that position: .

Why This Matters

This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Laura Clague

GNSS Forms 3/4/5

Genasys Inc.

Relationship: Director
Holdings value: $529,675
Past year net change
Change %
Report period: 27 Apr 2022

LAB Forms 3/4/5

STANDARD BIOTOOLS INC.

Relationship: Director
Holdings value: $398,490
Past year net change
Change %
Report period: 14 Jun 2023

TVTX Forms 3/4/5

Travere Therapeutics, Inc.

Relationship: Chief Financial Officer
Holdings value: $319,469
Past year net change
Change %
Report period: 10 May 2022

Insider Transactions Reported by Laura Clague:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.